There are currently 441 clinical trials in Las Vegas, Nevada looking for participants to engage in research studies. Trials are conducted at various facilities, including Comprehensive Cancer Centers of Nevada, University Medical Center of Southern Nevada, Summerlin Hospital Medical Center and GSK Investigational Site. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Engage for Late-Life Depression and Comorbid Executive Dysfunction
NCT05356611
Recruiting
Although there are an increasing number of mental health treatment adaptations for older adults, there are still a number of factors to consider when making these adaptations. Cognitive decline is one such factor that places significant burden on older adults and can interfere with traditional mental health therapies. Engage is a behavioral treatment approach that has shown to be effective in treating late life depression. The investigators are testing the feasibility of Engage as a treatment me... Read More
Gender:
All
Ages:
60 years and above
Trial Updated:
05/08/2023
Locations: University of Nevada, Las Vegas, Nevada
Conditions: Depression in Old Age, Psychotherapy, Mild Cognitive Impairment, Executive Dysfunction
Register for Updates
Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction
NCT05049070
Recruiting
This study evaluates the reliability, validity and safety of a self administered, subjective refraction test via a mobile medical app (GoEyes) as compared to standard of care subjective manifest refraction performed by a health care provider, in subjects who have no known ocular disease or condition other than refractive error.
Gender:
All
Ages:
Between 18 years and 39 years
Trial Updated:
04/04/2023
Locations: IMA Research, Las Vegas, Nevada
Conditions: Refractive Errors
Register for Updates
Operant Conditioning of Reflex Pathways to Improve Walking in Individuals Post-stroke
NCT05801744
Recruiting
The purpose of this study is to examine the changes in reflex pathways in the paretic ankle plantarflexors in individuals with post-stroke hemiparesis using operant conditioning. We are recruiting 5 individuals with chronic post-stroke hemiparesis with foot drop in the affected leg to participate in the reflex training procedure. The study involves 40 visits with a total study duration of about 4 months.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/24/2023
Locations: University of Nevada, Las Vegas, Las Vegas, Nevada
Conditions: Stroke, Post-stroke Hemiparesis, Foot Drop
Register for Updates
A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors
NCT04452955
Recruiting
This is a multi-center, Phase 2, open-label, single dose level study of PRL3-zumab monotherapy in patients with unresectable or metastatic solid tumor.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/28/2023
Locations: Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada
Conditions: Solid Tumor
Register for Updates
The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors
NCT04768868
Recruiting
A Phase 1 Dose Escalation and Expansion Study of IMP7068 Monotherapy in Advanced Solid Tumors
Gender:
All
Ages:
18 years and above
Trial Updated:
02/23/2023
Locations: Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada
Conditions: Advanced Solid Tumors
Register for Updates
Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)
NCT04502316
Recruiting
The purpose of this registry is to develop valid scientific evidence of the safety and benefit of Barostim Therapy in the commercial setting in patients with heart failure with reduced ejection fraction (HFrEF) that were recently implanted with the Barostim System.
Gender:
All
Ages:
All
Trial Updated:
01/21/2023
Locations: Nevada Heart and Vascular Center, Las Vegas, Nevada
Conditions: Heart Failure
Register for Updates
Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
NCT04931823
Recruiting
This is a Phase 1, multicenter, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary evidence of antitumor activity of CPO-100 administered intravenously in cycles of 3 weekly doses with 1 week rest (1 cycle = 4 weeks) in adult patients with advanced solid tumors.
Gender:
All
Ages:
18 years and above
Trial Updated:
12/16/2022
Locations: Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada
Conditions: Solid Tumor
Register for Updates
An Uneven Terrain Surface to Improve Locomotor Robustness in People With Amputation
NCT05560061
Recruiting
To attain high levels of mobility, people with lower limb amputation must build both the skill and the confidence to rely on their prosthesis in the environments that they will encounter in daily life. The purpose of this research is to determine whether practicing walking on an uneven terrain surface, specifically designed to present a modest, manageable disturbance to walking, can improve balance, locomotor flexibility (i.e. the ability to adapt walking to different walking contexts) and balan... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
11/23/2022
Locations: University of Nevada Las Vegas, Las Vegas, Nevada
Conditions: Amputation
Register for Updates
2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C
NCT04012996
Recruiting
A multi-center, prospective, randomized, controlled comparison of the prodisc C SK and prodisc C Vivo to the control, a similar, legally marketed total disc replacement device in subjects with symptomatic cervical disc disease (SCDD).
Gender:
All
Ages:
Between 18 years and 69 years
Trial Updated:
10/27/2022
Locations: Las Vegas Neurosurgical Institute for Spine and Brain Surgery, Las Vegas, Nevada
Conditions: Symptomatic Cervical Disc Disease
Register for Updates
Parkinson's Research With Inclusion, Diversity and Equity
NCT05556993
Recruiting
The purpose of this study is to identify the health and healthcare needs of LGBTQIA+ and non LGBTQIA+ communities living with Parkinson's disease.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/05/2022
Locations: University of Nevada, Las Vegas, Las Vegas, Nevada
Conditions: Parkinson Disease
Register for Updates
FTIH of ECC4703 in Healthy Volunteers
NCT05552274
Recruiting
This is a Phase 1, randomized, double-blind, placebo-controlled, single ascending dose and multiple ascending dose study of ECC4703 in healthy volunteers and participants with treatment unnecessary LDL-C under 160 mg/dL
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
09/20/2022
Locations: Eccogene Investigational Site, Las Vegas, Nevada
Conditions: Non-alcoholic Steatohepatitis (NASH)
Register for Updates
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
NCT04880187
Recruiting
This study will compare the effects of AXA1125, an orally active mixture of amino acids, compared to placebo, on improving fat and inflammation (steatohepatitis) as well as fibrosis in subjects with non alcoholic steatohepatitis (NASH). as well as the safety and tolerability of AXA1125. Subjects will take one of two different doses of AXA1125 or a placebo twice daily, and a liver biopsy will be done at the beginning and end of the 48-week study.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/07/2022
Locations: Jubilee Clinical Research, Inc., Las Vegas, Nevada +1 locations
Conditions: Non Alcoholic Steatohepatitis (NASH)
Register for Updates